Article
Tolerability of Breast Radiotherapy Among Carriers of ATM Germline Variants.
JCO precision oncology - 1 Jan 2021
Modlin Leslie A, Flynn Jessica, Zhang Zhigang, Cahlon Oren, Mueller Boris, Khan Atif J, Gillespie Erin F, McCormick Beryl, Stadler Zsofia K, Robson Mark E, Powell Simon N, Braunstein Lior Z
Abstract excerpt
ATM, a gene that controls repair of DNA double-strand breaks, confers an excess lifetime risk of breast cancer among carriers of germline pathogenic variants (PV). ATM PV homozygotes are particularly sensitive to DNA damage caused by ionizing radiation. Consequently, there is concern that adjuvant radiotherapy (RT) may cause excess morbidity among heterozygous carriers of ATM PV. We evaluated the tolerability of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
